IAM analyst estimates

Iambic Therapeutics (IAM) analyst ratings, the average price target and its range, and every firm's latest call.

• 0 firms rate IAM: 0 buy, 0 hold, 0 sell.
• The average price target is $35.00 from None analysts, from $35.00 to $35.00.

Updated 2026-11-11 00:47 UTC